Andreas Sarantopoulos

Dr. Andreas Sarantopoulos

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ASAndreas Sarantopoulos
Andreas Sarantopoulos
CKChristina Mastori Kourmpani
Christina Mastori Kourmpani
AYAtshaya Lily Yokarasa
Atshaya Lily Yokarasa
CMChiedza Makamanzi
Chiedza Makamanzi
PAPolyna Antoniou
Polyna Antoniou
Constantinos TsioutisConstantinos Tsioutis
Constantinos Tsioutis
The integration of artificial intelligence (AI) in clinical medicine marks a revolutionary shift, enhancing diagnostic accuracy, therapeutic efficacy, and overall healthcare delivery. This review explores the current uses, benefits, limitations, and future applications of AI in infectious diseases, highlighting its specific applications in diagnostics, clinical decision making, and personalized medicine. The transformative potential of AI in infectious diseases is emphasized, addressing gaps in rapid and accurate disease diagnosis, surveillance, outbreak detection and management, and treatment optimization. Despite these advancements, significant limitations and challenges exist, including data privacy concerns, potential biases, and ethical dilemmas. The article underscores the need for stringent regulatory frameworks and inclusive databases to ensure equitable, ethical, and effective AI utilization in the field of clinical and laboratory infectious diseases.

23 October 2024 in npj Precision Oncology
Verified
Journal Article
Open access
PDF file
ASAndreas Sarantopoulos
Andreas Sarantopoulos
CEChibawanye Ene
Chibawanye Ene
EAElisa Aquilanti
Elisa Aquilanti
Immunomodulatory therapies, including immune checkpoint inhibitors, have drastically changed outcomes for certain cancer types over the last decade. Gliomas are among the cancers that have seem limited benefit from these agents, with most trials yielding negative results. The unique composition of the glioma immune microenvironment is among the culprits for this lack of efficacy. In recent years, several efforts have been made to improve understanding of the glioma immune microenvironment, aiming to pave the way for novel therapeutic interventions. In this review, we discuss some of the main components of the glioma immune microenvironment, including macrophages, myeloid-derived suppressor cells, neutrophils and microglial cells, as well as lymphocytes. We then provide a comprehensive overview of novel immunomodulatory agents that are currently in clinical development, namely oncolytic viruses, vaccines, cell-based therapies such as CAR-T cells and CAR-NK cells as well as antibodies and peptides.

2 July 2025 in Health Economics and Management Review
Verified
Journal Article
Open access
PDF file
Iakovos KritikosIakovos Kritikos
Iakovos Kritikos
ASAndreas Sarantopoulos
Andreas Sarantopoulos
ARAnastasios Roumeliotis
Anastasios Roumeliotis
JVJulia Vasiliades
Julia Vasiliades
IMIoannis Matsinas
Ioannis Matsinas
NUNull
Null
The integration of artificial intelligence into drug discovery processes represents a major innovation in pharmaceutical research and development. This study investigates the role of AI investments in enhancing research efficiency, addressing implementation challenges, and shaping stakeholder perspectives. Via a structured explanatory research design, the study applies a quantitative methodology based on survey data collected from researchers, investors, and pharmaceutical executives across the USA and United Kingdom. The questionnaire examined respondents’ experiences with artificial intelligence tools, investment patterns, and perceived research outcomes. Statistical methods such as logistic regression and chi-square tests were employed to analyze correlations between investment strategies and research efficiency. Findings indicate that while artificial intelligence improves productivity – in predictive modeling and data analysis – barriers such as high infrastructure costs, inadequate training, and regulatory uncertainty persist. Notably, 70% of participants plan to increase AI investments within the next five years, and 80% regard artificial intelligence as essential or very important to the future of drug discovery. However, successful implementation appears to correlate with firm size and access to technical resources, suggesting disparities in AI readiness across the industry. Recommendations include expanding artificial intelligence training programs, strengthening infrastructure, and fostering closer collaboration between investors and researchers. Ethical considerations, including data privacy and regulatory compliance, are also emphasized. The pilot study provides foundational insights for a full-scale investigation and offers practical guidance for optimizing artificial intelligence integration in pharmaceutical research and development.

6 May 2026 in Journal of Medical Education and Curricular Development
Verified
Journal Article
Open access
ASAndreas Sarantopoulos
Andreas Sarantopoulos
Zoi Dorothea PanaZoi Dorothea Pana
Zoi Dorothea Pana
ALAndreas Larentzakis
Andreas Larentzakis
SKSophia Kondylis
Sophia Kondylis
AMAnna Maina
Anna Maina
DNDimitrios Ntourakis
Dimitrios Ntourakis
Background: Artificial intelligence (AI), particularly large language models like vision-capable ChatGPT 4.0, is increasingly shaping medical education. While these systems show promise for automated feedback and adaptive assessments, their performance in visually intensive, image-based disciplines remains insufficiently studied. Objective: This cohort study aims to compare the performance of ChatGPT 4.0 and undergraduate medical students on standardized, image-based multiple-choice questions in Anatomy, Pathology, and Pediatrics. Standardized exams were administered to second-, third-, and fifth-year students, and the same questions were submitted to ChatGPT 4.0 using a two-step deterministic and stochastic protocol. Items with images that ChatGPT 4.0 failed to recognize were excluded. The statistical unit of analysis was the question, and all questions were analyzed as independent question-level observations within each domain. Paired t-tests or Wilcoxon signed-rank tests were used as appropriate, and subgroup analyses were restricted to questions with a discrimination index ≥ 0.1. Results: Of 90 questions, 52 were eligible for the primary comparative analysis after exclusion of items in which ChatGPT 4.0 failed image recognition. ChatGPT 4.0 significantly underperformed students in Anatomy (mean difference = -0.387, p < 0.00001, Cohen’s d = 2.10) but outperformed students in Pediatrics (mean difference = +0.174, p = 0.00013, Cohen’s d = 0.81); these findings were similar or stronger in discrimination-based subgroup analyses. No Pathology items were eligible for comparative analysis because ChatGPT 4.0 failed image recognition for all Pathology images; therefore, no inference about comparative downstream reasoning can be made for Pathology under this protocol. In the global end-to-end analysis, which scored image-recognition failures as incorrect, ChatGPT 4.0 accuracy was 17.3% in Anatomy, 84.9% in Pediatrics, and 0% in Pathology. Conclusion: These findings demonstrate marked variability in ChatGPT’s visual reasoning across medical domains, underscoring the need for multimodal integration and critical evaluation of AI applications before adoption in image-dependent medical education settings.

4 February 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ASAndreas Sarantopoulos
Andreas Sarantopoulos
MMMaria Marinakis
Maria Marinakis
NSNikolaos Christos Schizas
Nikolaos Christos Schizas
DIDimitrios ILIOPOULOS
Dimitrios ILIOPOULOS
Background: Augmented reality (AR) and mixed reality (MR) promise to enhance anatomical understanding, spatial orientation, and workflow in cardiac surgery. Their clinical adoption remains limited and the translational path is incompletely defined. Methods: A PubMed search was conducted by two independent reviewers from database inception through July 2025 and identified peer-reviewed, English-language articles describing peri- or intra-operative AR/MR applications in cardiac surgery. Relevant clinical, preclinical, technical, and review articles were selected for inclusion based on scope and content. Given the narrative approach and heterogeneity across studies, findings were synthesized qualitatively into application domains. Results: Fourteen studies were included. Five domains emerged: (1) preoperative planning and patient-specific modelling—MR enhanced spatial orientation and planning for minimally invasive and valve procedures; (2) intraoperative navigation and visualization—AR improved targeting and interpretation with preclinical overlay errors ≈ 5 mm; (3) physiological/functional guidance—thermographic AR detected ischemia in vivo with strong correlation to invasive thermometry; (4) robotic integration and workflow optimization—AR-guided port placement and stepwise robotic adoption supported the feasibility of totally endoscopic CABG; (5) AR-based early rehabilitation. Conclusions: Early clinical and preclinical evidence supports AR/MR feasibility and utility for visualization and orientation in cardiac surgery. Priorities include deformable, motion-compensated registration, ergonomic integration with robotic platforms, and multicentre trials powered for operative efficiency and patient outcomes.

5 January 2026 in Global Surgical Education - Journal of the Association for Surgical Education
Verified
Journal Article
Closed access
ASAndreas Sarantopoulos
Andreas Sarantopoulos
Zoi Dorothea PanaZoi Dorothea Pana
Zoi Dorothea Pana
ALAndreas Larentzakis
Andreas Larentzakis
SKSophia Kondylis
Sophia Kondylis
AMAnna Maina
Anna Maina
DNDimitrios Ntourakis
Dimitrios Ntourakis